- Title: Subtitle
- SCHOLAR-1 versus ZUMA-1: A Standardized Comparison of Outcomes in Patients (Pts) with Refractory, Aggressive Non-Hodgkin Lymphoma (rNHL)
- Creators
- Sattva Neelapu - The University of Texas MD Anderson Cancer CenterFrederick Locke - Moffitt Cancer CenterNancy Bartlett - Washington University in St. LouisLazaros Lekakis - University of MiamiPatrick Reagan - University of RochesterDavid Miklos - Stanford UniversityCaron Jacobson - Dana-Farber Cancer InstituteIra Braunschweig - Montefiore Medical CenterOlalekan Oluwole - Vanderbilt University Medical CenterTanya Siddiqi - City Of Hope National Medical CenterYi Lin - Mayo ClinicMichael Crump - Queen's UniversityJohn Kuruvilla - Queen's UniversityEric Van den Neste - The Lymphoma Academic Research OrganisationBrian Link - University of IowaUmar Farooq - University of IowaLynn Navale - KiteWillilam Go - KiteJeffrey Wiezorek - KiteChristian Gisselbrecht - The Lymphoma Academic Research Organisation
- Resource Type
- Abstract
- Publication Details
- Clinical lymphoma, myeloma and leukemia, Vol.17, pp.S362-S363
- Publisher
- Elsevier Inc
- DOI
- 10.1016/j.clml.2017.07.197
- ISSN
- 2152-2650
- eISSN
- 2152-2669
- Language
- English
- Date published
- 09/2017
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984362347902771
Abstract
SCHOLAR-1 versus ZUMA-1: A Standardized Comparison of Outcomes in Patients (Pts) with Refractory, Aggressive Non-Hodgkin Lymphoma (rNHL)
Clinical lymphoma, myeloma and leukemia, Vol.17, pp.S362-S363
09/2017
DOI: 10.1016/j.clml.2017.07.197
Details
Metrics
4 Record Views